High levels of LAG-3 in HCC patients are accompanied by cirrhosis, elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and the progression of Barcelona Clinic Liver Cancer (BCLC) stage (70). The gene discussed is GPT; the disease is hepatocellular carcinoma.